Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Houssem Benlalam

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|February 23, 2011
Cytotoxic T cells - stroma interactionsMuhammad Zaeem Noman, Houssem Benlalam, Meriem Hasmim, et al.
Medecine Sciences : M/S|September 12, 2006
[Immunotherapy of cancer: promise and reality]Salem Chouaib, Faten El Hage, Houssem Benlalam, et al.
Critical Reviews in Immunology|December 24, 2010
Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cellsSalem Chouaib, Claudine Kieda, Houssem Benlalam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesionBoris Linard, Stéphane Bézieau, Houssem Benlalam, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 8, 2013
Regulation of gap junctions in melanoma and their impact on Melan-A/MART-1-specific CD8⁺ T lymphocyte emergenceHoussem Benlalam, Thibault Carré, Abdelali Jalil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2014
Soluble HLA-I/peptide monomers mediate antigen-specific CD8 T cell activation through passive peptide exchange with cell-bound HLA-I moleculesMathilde Allard, Romain Oger, Houssem Benlalam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytesHoussem Benlalam, Boris Linard, Yannik Guilloux, et al.
Cancer Immunology, Immunotherapy : CII|July 29, 2006
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patientsHoussem Benlalam, Virginie Vignard, Amir Khammari, et al.
Cancer Immunology, Immunotherapy : CII|May 30, 2018
Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicityJocelyn Ollier, Thibault Kervarrec, Mahtab Samimi, et al.
Vaccines|February 13, 2021
Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-CellsKevin Lenogue, Alexandre Walencik, Karine Laulagnier, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|February 23, 2011
Cytotoxic T cells - stroma interactionsMuhammad Zaeem Noman, Houssem Benlalam, Meriem Hasmim, et al.
Medecine Sciences : M/S|September 12, 2006
[Immunotherapy of cancer: promise and reality]Salem Chouaib, Faten El Hage, Houssem Benlalam, et al.
Critical Reviews in Immunology|December 24, 2010
Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cellsSalem Chouaib, Claudine Kieda, Houssem Benlalam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesionBoris Linard, Stéphane Bézieau, Houssem Benlalam, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 8, 2013
Regulation of gap junctions in melanoma and their impact on Melan-A/MART-1-specific CD8⁺ T lymphocyte emergenceHoussem Benlalam, Thibault Carré, Abdelali Jalil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2014
Soluble HLA-I/peptide monomers mediate antigen-specific CD8 T cell activation through passive peptide exchange with cell-bound HLA-I moleculesMathilde Allard, Romain Oger, Houssem Benlalam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytesHoussem Benlalam, Boris Linard, Yannik Guilloux, et al.
Cancer Immunology, Immunotherapy : CII|July 29, 2006
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patientsHoussem Benlalam, Virginie Vignard, Amir Khammari, et al.
Cancer Immunology, Immunotherapy : CII|May 30, 2018
Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicityJocelyn Ollier, Thibault Kervarrec, Mahtab Samimi, et al.
Vaccines|February 13, 2021
Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-CellsKevin Lenogue, Alexandre Walencik, Karine Laulagnier, et al.
Pageof 2